Literature DB >> 8872946

Polymorphisms of the renin-angiotensin system genes in progressive renal diseases.

H Yoshida, V Kon, I Ichikawa.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8872946     DOI： 10.1038/ki.1996.371

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  8 in total

Review 1.  Antihypertensive drugs and diabetic nephropathy.

Authors:  P S Mehler; R W Schrier
Journal:  Curr Hypertens Rep       Date:  1999 Apr-May       Impact factor: 5.369

Review 2.  Progression of glomerular and tubular disease in pediatrics.

Authors:  Robert P Woroniecki; H William Schnaper
Journal:  Semin Nephrol       Date:  2009-07       Impact factor: 5.299

3.  Is ACE gene polymorphism a risk factor for renal scarring with low-grade reflux?

Authors:  Hakan Erdoğan; Sevgi Mir; Erkin Serdaroğlu; Afig Berdeli; Nejat Aksu
Journal:  Pediatr Nephrol       Date:  2004-05-12       Impact factor: 3.714

4.  ACE and AT1 receptor gene polymorphisms and renal scarring in urinary bladder dysfunction.

Authors:  Mirjana Kostić; Aleksandra Stanković; Maja Zivković; Amira Peco-Antić; Olga Jovanović; Dragan Alavantić; Divna Kruscić
Journal:  Pediatr Nephrol       Date:  2004-06-04       Impact factor: 3.714

Review 5.  Kidney disease in African Americans: genetic considerations.

Authors:  Deborah A Price; Errol D Crook
Journal:  J Natl Med Assoc       Date:  2002-08       Impact factor: 1.798

6.  Angiotensin converting enzyme gene polymorphism and influence of ACE inhibition.

Authors:  Q Arman
Journal:  Indian J Nephrol       Date:  2010-10

7.  ACE gene polymorphism and renal responsiveness to ACE inhibitors in IgA nephropathy patients.

Authors:  S Y Han; Y J Kwon; S K Jo; J H Shin; D R Cha; W Y Cho; H J Pyo; H K Kim
Journal:  Korean J Intern Med       Date:  2000-01       Impact factor: 2.884

8.  Mechanisms of progression of chronic kidney disease.

Authors:  Agnes B Fogo
Journal:  Pediatr Nephrol       Date:  2007-07-24       Impact factor: 3.714
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.